ASTS vs JAZZ · rev $4.4M vs P/E 1988, rev $4.07B
Ast Spacemobile Inc (ASTS) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Ast Spacemobile Inc (ASTS) is a communication equipment company listed on NASDAQ.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported ASTS revenue for 2024-12-31 was $4.4M. Net income was -$526.3M. ASTS currently screens at market cap $33.16B.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
ASTS currently screens at market cap $33.16B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the ASTS and JAZZ stock pages for the full models.
Not investment advice.